Posted in📊 Economic & Market Analysis
AI-Powered Drug Discovery: How Machine Learning Could Unlock New Antibiotic Revenue Streams
AI in biotech investing is gaining momentum as UK scientists lead a three-year initiative to combat antibiotic-resistant superbugs using machine learning. This article explores the science, investment landscape, key players like Recursion and Insilico Medicine, and the risk-return dynamics of AI-driven drug development.
